Summary
Highlights
Despite advancements in other fields, curing cancer remains a formidable challenge. Cancer arises from normal cells accumulating mutations, which sometimes allow uncontrolled growth, invasion of tissues, and metastasis. Cancer is not a single disease but over 100 different types, each requiring a specific approach.
Current treatments often involve surgery, radiation, and chemotherapy, sometimes supplemented by hormone therapies, immunotherapy, or targeted treatments. While effective in many cases, these treatments are not 100% successful, prompting the need for new approaches.
Current research heavily relies on lab-grown cell lines, which lack the complexity of tumors in living organisms. This discrepancy often leads to drugs that work in labs failing clinical trials, highlighting the need for better study methods.
Aggressive tumors exhibit clonal heterogeneity, meaning they consist of multiple populations of cancerous cells with distinct genetic mutations. This makes treatment difficult as a drug effective against one subclone may not affect another. Additionally, tumors are dynamic ecosystems where cancer cells communicate with each other and healthy cells, even suppressing the immune system.
Eradicating cancer stem cells is crucial, as these rare cells are resistant to chemotherapy and radiation and can re-seed new tumors. Furthermore, cancer cells are masters of adaptation, constantly evolving and adjusting their characteristics to survive stress, such as radiation or chemotherapy, by changing their gene expression.
To defeat cancer, research needs to find experimental systems that match the complexity of tumors, along with monitoring and treatment options that can adapt to changing cancer. Despite these challenges, significant progress is being made, with the average mortality rate for most cancers having dropped significantly since the 1970s and continuing to fall, indicating that new knowledge continually strengthens our arsenal against the disease.